Literature DB >> 3054773

Inflammatory response in enterocolitis in the piebald lethal mouse model of Hirschsprung's disease.

T Fujimoto1, D J Reen, P Puri.   

Abstract

Mucosal immune defense responses in two clinical forms of enterocolitis complicating congenital megacolon in the piebald lethal mouse model of Hirschsprung's disease were investigated. Significant histological and immunocytochemical differences were seen in the ganglionic segment of colon between piebald mice with early clinical onset of acute illness and piebald mice with late onset enterocolitis. The number of IgA-containing plasma cells infiltrating the lamina propria of the gut in the former group were significantly increased (p less than 0.001) compared to the latter group of mice and healthy controls. This study suggests that the two forms of enterocolitis complicating congenital megacolon in piebald mice have different etiologies.

Entities:  

Mesh:

Year:  1988        PMID: 3054773     DOI: 10.1203/00006450-198808000-00002

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

Review 1.  The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.

Authors:  Bryan B Yoo; Sarkis K Mazmanian
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

Review 2.  New insights into the pathogenesis of Hirschsprung's associated enterocolitis.

Authors:  Feilim Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2005-09-30       Impact factor: 1.827

Review 3.  Hirschsprung's disease: clinical and experimental observations.

Authors:  P Puri
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

4.  Murine model of Hirschsprung-associated enterocolitis. I: phenotypic characterization with development of a histopathologic grading system.

Authors:  Zhi Cheng; Deepti Dhall; Lifu Zhao; Hanlin L Wang; Terence M Doherty; Catherine Bresee; Philip K Frykman
Journal:  J Pediatr Surg       Date:  2010-03       Impact factor: 2.545

5.  Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung's disease.

Authors:  Joseph F Pierre; Amanda J Barlow-Anacker; Christopher S Erickson; Aaron F Heneghan; Glen E Leverson; Scot E Dowd; Miles L Epstein; Kenneth A Kudsk; Ankush Gosain
Journal:  J Pediatr Surg       Date:  2014-08       Impact factor: 2.545

6.  Induction of RET dependent and independent pro-inflammatory programs in human peripheral blood mononuclear cells from Hirschsprung patients.

Authors:  Marta Rusmini; Paola Griseri; Francesca Lantieri; Ivana Matera; Kelly L Hudspeth; Alessandra Roberto; Joanna Mikulak; Stefano Avanzini; Valentina Rossi; Girolamo Mattioli; Vincenzo Jasonni; Roberto Ravazzolo; William J Pavan; Alessio Pini-Prato; Isabella Ceccherini; Domenico Mavilio
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

Review 7.  Balancing on the crest - Evidence for disruption of the enteric ganglia via inappropriate lineage segregation and consequences for gastrointestinal function.

Authors:  Melissa A Musser; E Michelle Southard-Smith
Journal:  Dev Biol       Date:  2013-01-31       Impact factor: 3.582

8.  Altered goblet cell function in Hirschsprung's disease.

Authors:  Hiroki Nakamura; Christian Tomuschat; David Coyle; Anne-Marie O'Donnel; Tristan Lim; Prem Puri
Journal:  Pediatr Surg Int       Date:  2018-01-30       Impact factor: 1.827

9.  Murine model of Hirschsprung-associated enterocolitis II: Surgical correction of aganglionosis does not eliminate enterocolitis.

Authors:  Lifu Zhao; Deepti Dhall; Zhi Cheng; Hanlin L Wang; Terence M Doherty; Catherine Bresee; Philip K Frykman
Journal:  J Pediatr Surg       Date:  2010-01       Impact factor: 2.545

10.  Impaired Cellular Immunity in the Murine Neural Crest Conditional Deletion of Endothelin Receptor-B Model of Hirschsprung's Disease.

Authors:  Ankush Gosain; Amanda J Barlow-Anacker; Chris S Erickson; Joseph F Pierre; Aaron F Heneghan; Miles L Epstein; Kenneth A Kudsk
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.